## Abstract Naturally occurring CD4^+^ regulatory T cells can be identified on the basis of expression of CD25 and suppression of T cell responses __in vitro__ after TCR triggering. Here, we demonstrate that a CD134^+^ subset of CD4^+^CD25^+^ T cells in naive rats suppresses antigen‐specific T cell
CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo
✍ Scribed by Christopher M. Smith; Gustavo T. L. Rosa; Janet S. May; Neil J. Bennett; Adele M. Mount; Gabrielle T. Belz; Philip G. Stevenson
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 460 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Melanoma‐associated chondroitin sulfate proteoglycan (MCSP) (also known as high molecular weight‐melanoma‐associated antigen) represents an interesting target antigen for cancer immunotherapy which is expressed on human melanomas and other tumors such as breast carcinomas, gliomas, neur
## Abstract The basis of the adjuvant effect of IL‐1 on the clonal expansion of Ag‐specific CD4 T cells was measured __in vivo__ using the TCR transgenic T cell adoptive transfer method. Injection ofAg plus IL‐1 caused naive CD4 T cells to proliferate to a greater extent than did injection of Ag al
## Abstract ## Objective Although studies have suggested that human cartilage (HC) gp‐39 may be an antigen recognized by autoreactive CD4+ T cells in rheumatoid arthritis, we previously failed to identify specific CD4+ T cells in patients' synovial fluid or blood using a class II major histocompat
In cancer patients, NK cell inhibitory receptors (IR) are expressed on a fraction of melanomaspecific lymphocytes with a unique reactivity for tumor antigens derived from normal, nonmutated genes (differentiation antigens). It is presently not known whether expression of these receptors is induced d